The American journal on addictions · 2024
Extended-release buprenorphine in pregnancy.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hubbell Alexander, Aghenta Ese, Jones Cresta, Specker Sheila
Аннотация
BACKGROUND AND OBJECTIVES: The relative safety and efficacy of monthly extended-release buprenorphine (XR-BUP) has not been fully evaluated in pregnant persons.
METHODS: Case report of two pregnant individuals receiving XR-BUP while pregnant.
RESULTS: Both patients had positive experiences and healthy infants.
DISCUSSION AND CONCLUSIONS: Sparse data regarding the use of XR-BUP in pregnant patients limits shared decision-making. Additional evidence will support the growing population of pregnant patients exposed to XR-BUP.
SCIENTIFIC SIGNIFICANCE: Positive patient experiences using XR-BUP during pregnancy have been previously unreported. This report will contribute to discussions of risks and benefits for future patients using XR-BUP during pregnancy.
METHODS: Case report of two pregnant individuals receiving XR-BUP while pregnant.
RESULTS: Both patients had positive experiences and healthy infants.
DISCUSSION AND CONCLUSIONS: Sparse data regarding the use of XR-BUP in pregnant patients limits shared decision-making. Additional evidence will support the growing population of pregnant patients exposed to XR-BUP.
SCIENTIFIC SIGNIFICANCE: Positive patient experiences using XR-BUP during pregnancy have been previously unreported. This report will contribute to discussions of risks and benefits for future patients using XR-BUP during pregnancy.